Then, to find potential SOS1 inhibitors for RAS-driven cancers, the InterBioScreen database (https://www.ibscreen.com/, accessed on 27 July 2022), consisting of 67,631 natural compounds, was screened for the ligand binding site and the two putative allosteric sites. This evidence concerns the gene SOS1 and cancer.